NEW YORK, Dec. 9, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily market update directly from…
All three dose groups (50 mg, 100 mg and 200 mg) showed impressive monotherapy efficacy, with VGPR+ (very good partial…
Senior executives of business and finance, civil society, the United Nations and Government met on the margins of the United…
PARIS, Sept. 15, 2025 /PRNewswire/ -- Four Seasons Hotel George V, Paris has completed a three-year transformation project that saw…
Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma Approval based on GMMG-HD7 phase…
Newly Developed Structure Fusing Different Materials TOKYO, May 27, 2025 /PRNewswire/ -- Casio Computer Co., Ltd. announced today the latest addition…